A six-month crossover chemoprevention clinical trial of tea in smokers and non-smokers: methodological issues in a feasibility study

• Egile Nagusiak: Dash Chiranjeev (Egilea), Chung Fung-Lung (Egilea), Rohan Joy Ann (Egilea), Greenspan Emily (Egilea), Christopher Patrick D (Egilea), Makambi Kepher (Egilea), Hara Yukihiko (Egilea), Newkirk Kenneth (Egilea), Davidson Bruce (Egilea), Adams-Campbell Lucile L (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2012-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Chemoprevention crossover trials of tea can be more efficient than parallel designs but the attrition and compliance rates with such trials are unknown.</p> <p>Methods</p> <p>Attrition (dropouts) and complianc...